Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Modified GnP in metastatic pancreatic cancer
NCT03502343Phase 2Unknown
- Sponsor
- Yonsei University
- Start
- Apr 2018
- Primary completion
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of paclitaxel, sponsored by Yonsei University. Primary endpoints: Objective response rate and Disease control rate. Status: unknown.
02
Drugs
paclitaxel
Beyond the preview
Go deeper on NCT03502343.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03502343.